Jennifer Possick, MD
Associate Professor Term; Medical Director, Post-COVID Recovery Program, Winchester Chest Center; Medical Director, Winchester Center for Lung Disease, Winchester Center for Lung Disease
Research & Publications
Biography
News
Coauthors
Selected Publications
- “Long Haulers”Lutchmansingh D, Sevilla J, Possick J, Gulati M. “Long Haulers” Seminars In Respiratory And Critical Care Medicine 2023, 44: 130-142. PMID: 36646091, DOI: 10.1055/s-0042-1759568.
- Welcome to the Real World Understanding the Many Faces of Osimertinib-Related PneumonitisPossick J. Welcome to the Real World Understanding the Many Faces of Osimertinib-Related Pneumonitis CHEST Journal 2022, 162: 965-967. PMID: 36344125, DOI: 10.1016/j.chest.2022.06.020.
- AMBULATORY BLOCK STRUCTURE TO IMPROVE FELLOW OUTPATIENT PULMONARY MEDICINE EXPOSURE AND EDUCATIONMCAVOY K, POSSICK J, HONIDEN S. AMBULATORY BLOCK STRUCTURE TO IMPROVE FELLOW OUTPATIENT PULMONARY MEDICINE EXPOSURE AND EDUCATION CHEST Journal 2022, 162: a2599. DOI: 10.1016/j.chest.2022.08.2124.
- Impaired Stressed Blood Volume Augmentation in Post-COVID-19 PatientsSavarimuthu S, Joseph P, Lutchmansingh D, Possick J, Gulati M, Cullinan M, Kreiger J, Heerdt P, Singh I. Impaired Stressed Blood Volume Augmentation in Post-COVID-19 Patients 2022, a5418-a5418. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a5418.
- Abstract 6991: Impaired Systemic Oxygen Extraction Relates to Reduced Exercise Capacity in Post-COVID-19 Long Hauler SyndromeBiondi M, Joseph P, Gulati M, Possick J, Lutchmansingh D, Cullinan M, Heerdt P, Singh I. Abstract 6991: Impaired Systemic Oxygen Extraction Relates to Reduced Exercise Capacity in Post-COVID-19 Long Hauler Syndrome Circulation 2021, 144: a6991-a6991. DOI: 10.1161/circ.144.suppl_1.6991.
- UNEXPLAINED DYSPNEA IN A PATIENT WITH A HISTORY OF COVID-19Biondi M, Gulati M, Possick J, Joseph P, Singh I, Lutchmansingh D. UNEXPLAINED DYSPNEA IN A PATIENT WITH A HISTORY OF COVID-19 CHEST Journal 2021, 160: a2373-a2374. PMCID: PMC8503500, DOI: 10.1016/j.chest.2021.07.2054.
- Persistent Exertional Intolerance After COVID-19 Insights From Invasive Cardiopulmonary Exercise TestingSingh I, Joseph P, Heerdt PM, Cullinan M, Lutchmansingh DD, Gulati M, Possick JD, Systrom DM, Waxman AB. Persistent Exertional Intolerance After COVID-19 Insights From Invasive Cardiopulmonary Exercise Testing CHEST Journal 2021, 161: 54-63. PMID: 34389297, PMCID: PMC8354807, DOI: 10.1016/j.chest.2021.08.010.
- A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the FutureLutchmansingh DD, Knauert MP, Antin-Ozerkis DE, Chupp G, Cohn L, Dela Cruz CS, Ferrante LE, Herzog EL, Koff J, Rochester CL, Ryu C, Singh I, Tickoo M, Winks V, Gulati M, Possick JD. A Clinic Blueprint for Post-Coronavirus Disease 2019 RECOVERY Learning From the Past, Looking to the Future CHEST Journal 2020, 159: 949-958. PMID: 33159907, PMCID: PMC7641526, DOI: 10.1016/j.chest.2020.10.067.
- Pulmonary Complications of ImmunotherapyBade BC, Possick JD. Pulmonary Complications of Immunotherapy Clinics In Chest Medicine 2020, 41: 295-305. PMID: 32402364, DOI: 10.1016/j.ccm.2020.02.012.
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research StatementSears CR, Peikert T, Possick JD, Naidoo J, Nishino M, Patel SP, Camus P, Gaga M, Garon EB, Gould MK, Limper AH, Montgrain PR, Travis WD, Rivera MP. Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement American Journal Of Respiratory And Critical Care Medicine 2019, 200: e31-e43. PMID: 31518182, PMCID: PMC6775885, DOI: 10.1164/rccm.201906-1202st.
- Teaching Communication SkillsPossick J, Akgün K. Teaching Communication Skills 2019, 195-212. DOI: 10.1007/978-3-030-10680-5_11.
- Imatinib-Induced Pneumonitis Associated with "Radiation-Recall" Pattern in a Patient with Chronic Myelogenous Leukemia and Prior Chemotherapy, Radiation Therapy, and Immunotherapy for Non-Small Cell Lung CancerNaiditch H, Brandsdorfer C, Possick J. Imatinib-Induced Pneumonitis Associated with "Radiation-Recall" Pattern in a Patient with Chronic Myelogenous Leukemia and Prior Chemotherapy, Radiation Therapy, and Immunotherapy for Non-Small Cell Lung Cancer 2019, a1472-a1472. DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1472.
- Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life?Honiden S, Possick J. Should Physicians New to a Case Counsel Patients and Their Families to Change Course at the End of Life? The AMA Journal Of Ethic 2018, 20: e699-707. PMID: 30118419, DOI: 10.1001/amajethics.2018.699.
- A Young Man With Hemoptysis and Cavitary Lung LesionsBrady VA, Zinchuk AV, Siegel MD, Possick JD. A Young Man With Hemoptysis and Cavitary Lung Lesions CHEST Journal 2018, 153: e85-e88. PMID: 29626974, PMCID: PMC6026285, DOI: 10.1016/j.chest.2017.09.018.
- Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managingMedeiros BC, Possick J, Fradley M. Cardiovascular, pulmonary, and metabolic toxicities complicating tyrosine kinase inhibitor therapy in chronic myeloid leukemia: Strategies for monitoring, detecting, and managing Blood Reviews 2018, 32: 289-299. PMID: 29454474, DOI: 10.1016/j.blre.2018.01.004.
- Chapter 15 Diagnosis and Management of Treatment-Related Pulmonary ComplicationsPossick J. Chapter 15 Diagnosis and Management of Treatment-Related Pulmonary Complications 2018, 221-241. DOI: 10.1016/b978-0-323-48565-4.00015-1.
- Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic MelanomaReddy SB, Possick JD, Kluger HM, Galan A, Han D. Sarcoidosis Following Anti-PD-1 and Anti-CTLA-4 Therapy for Metastatic Melanoma Journal Of Immunotherapy 2017, 40: 307-311. PMID: 28737620, DOI: 10.1097/cji.0000000000000181.
- Pulmonary Disease in Non-Pulmonary MalignancyCheng GS, Possick JD. Pulmonary Disease in Non-Pulmonary Malignancy Clinics In Chest Medicine 2017, 38: xiii-xiv. PMID: 28477646, DOI: 10.1016/j.ccm.2017.03.001.
- Pulmonary Toxicities from Checkpoint Immunotherapy for MalignancyPossick JD. Pulmonary Toxicities from Checkpoint Immunotherapy for Malignancy Clinics In Chest Medicine 2017, 38: 223-232. PMID: 28477635, DOI: 10.1016/j.ccm.2016.12.012.
- Pulmonary Disease in Non-Pulmonary MalignancyCheng G, Possick J. Pulmonary Disease in Non-Pulmonary Malignancy Clinics In Chest Medicine 2017, 38: i. DOI: 10.1016/s0272-5231(17)30011-4.
- Pneumococcal Vaccination Strategies. An Update and PerspectiveBerical AC, Harris D, Dela Cruz CS, Possick JD. Pneumococcal Vaccination Strategies. An Update and Perspective Annals Of The American Thoracic Society 2016, 13: 933-944. PMID: 27088424, PMCID: PMC5461988, DOI: 10.1513/annalsats.201511-778fr.
- Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors.Gettinger S, Zhang X, Homer R, Possick J, Wurtz A, Goldberg S, Chiang A, Herbst R, Rubinowitz A. Pneumonitis in non-small cell lung cancer (NSCLC) patients treated with programmed death 1 (PD1) axis inhibitors. Journal Of Clinical Oncology 2016, 34: 9030-9030. DOI: 10.1200/jco.2016.34.15_suppl.9030.
- Tanoue LT, McArdle JR, Possick JD. Pulmonary Toxicity Associated with Chemotherapeutic Agents. In Grippi M, Elias J, Fishman J, et al. Fishman’s Pulmonary Diseases and Disorders, 5th edition. New York: McGraw-Hill, 2015Tanoue LT, McArdle JR, Possick JD. Pulmonary Toxicity Associated with Chemotherapeutic Agents. In Grippi M, Elias J, Fishman J, et al. Fishman’s Pulmonary Diseases and Disorders, 5th edition. New York: McGraw-Hill, 2015
- Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary DiseaseMost J, Possick J, Rochester C. Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease Clinical Pulmonary Medicine 2014, 21: 155-166. DOI: 10.1097/cpm.0000000000000044.
- Advances in the Outpatient Management of Chronic Obstructive Pulmonary DiseasePossick J, Most J, Rochester C. Advances in the Outpatient Management of Chronic Obstructive Pulmonary Disease Clinical Pulmonary Medicine 2013, 20: 259-270. DOI: 10.1097/cpm.0000000000000001.
- Intensive Care Unit Management of Status AsthmaticusMarshall P, Possick J, Chupp G. Intensive Care Unit Management of Status Asthmaticus Clinical Pulmonary Medicine 2009, 16: 293-301. DOI: 10.1097/cpm.0b013e3181bdff38.
- Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung FunctionOber C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of Variation in CHI3L1 on Serum YKL-40 Level, Risk of Asthma, and Lung Function New England Journal Of Medicine 2008, 358: 1682-1691. PMID: 18403759, PMCID: PMC2629486, DOI: 10.1056/nejmoa0708801.
- Most JF, Possick JD, Rochester C. Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease. Clin Pulm Med. 2014, 21(4):155-166Most JF, Possick JD, Rochester C. Systemic Manifestations and Comorbidities of Chronic Obstructive Pulmonary Disease. Clin Pulm Med. 2014, 21(4):155-166
- Marshall PS, Possick JD, Chupp GL. Intensive Care Unit Management of Status Asthmaticus. Clin Pulm Med. 2009, 16(6):293-301Marshall PS, Possick JD, Chupp GL. Intensive Care Unit Management of Status Asthmaticus. Clin Pulm Med. 2009, 16(6):293-301